Deka Bank Deutsche Girozentrale Allogene Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$10.32 - $17.28 $496,392 - $831,168	48,100 Added 92.68%	100,000 $1.04 Million
Q1 2022 Apr 28, 2022	BUY	$7.65 - $15.29 $5,355 - $10,703	700 Added 1.37%	51,900 $485,000
Q4 2021 Feb 02, 2022	BUY	$13.13 - $24.52 $17,069 - $31,876	1,300 Added 2.61%	51,200 $786,000
Q1 2021 Apr 28, 2021	BUY	$25.79 - $39.02 $103,160 - $156,080	4,000 Added 8.71%	49,900 $1.67 Million
Q4 2020 Mar 12, 2021	BUY	$25.24 - $43.45 $118,627 - $204,215	4,700 Added 11.41%	45,900 $1.24 Million
Q3 2020 Oct 29, 2020	BUY	$32.38 - $44.96 $1.33 Million - $1.85 Million	41,200 New	41,200 $1.55 Million
Q1 2020 May 14, 2020	SELL	$18.22 - $28.25 $123,203 - $191,026	-6,762 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$24.82 - $31.4 $167,832 - $212,326	6,762 New	6,762 $178,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.